LOADING
Comparing Walmart Inc (WMT) and Pfizer Inc (PFE) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | WMT | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $884.9B | $143.3B |
| P/E Ratio | 39.1 | 19.1 |
| Forward P/E | 38.2 | 8.5 |
| PEG Ratio | 4.24 | 2.94 |
| EPS | $2.84 | $1.31 |
| Revenue Growth (YoY) | 7.3% | 5.4% |
| Profit Margin | 3.1% | 11.8% |
| Return on Equity | 24.1% | 8.3% |
| Dividend Yield | 0.86% | 6.90% |
| Beta | 0.60 | 0.31 |
| 52-Week High | $135.16 | $27.80 |
| 52-Week Low | $94.85 | $22.03 |
| Volume | -- | -- |
Walmart Inc is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Pfizer Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.